tk88 bet

Vietnam hoped to produce COVID-19 vaccines in late Q3

Vietnam is expected to have the first batch of locally-produced COVID-19 vaccines at the end of the third quarter of 2021.
Vietnam hoped to produce COVID-19 vaccines in late Q3 ảnh 1Deputy Prime Minister Vu Duc Dam (Photo: VNA)
Hanoi (VNA) – Vietnam is expected to have the first batch oflocally-produced COVID-19 vaccines at the end of the third quarter of 2021.

The statement was made by Deputy Director of the Departmentof Science Technology and Training under the Health Ministry Nguyen Ngo Quang,who is Chief of the Office of the National Programme on Vaccine Research andDevelopment, at a meeting of the Standing Board of the Steering Committee for InternationalCooperation in Clinical Trials of COVID-19 Vaccines on March 22.

Quang said that Vietnam is currently making research onthree types of COVID-19 vaccine.

Accordingly, the second phase of human trials on NanoCovaxvaccine, produced by the Nanogen Pharmaceutical Biotechnology, is beingconducted, with the second dose to be injected on March 26.

The results of the second phase are expected to be announcedin May as scheduled, while the third phase will be conducted from May toSeptember. The vaccine is hoped to be registered for circulation in September,three months shorter than planned. Earlier, the trial time of the second phasewas also shortened from six months to three months.

A system on monitoring and assessing vaccines’ protectionefficiency in Vietnam and other countries is expected to be operated fromSeptember 2021 – September 2022.

Meanwhile, the first injections of the first phase of humantrials on Vietnam’s second homegrown candidate vaccine COVIVAC, developed bythe Institute of Vaccines and Medical Biologicals (IVAC), were made on March15.
Vietnam hoped to produce COVID-19 vaccines in late Q3 ảnh 2An overview of the meeting (Photo: VNA)
The first phase of human trials on the country’s third homegrowncandidate vaccine, developed by VABIOTECH, is hoped to begin in April.

Standing members of the Steering Committee for InternationalCooperation in Clinical Trials of COVID-19 Vaccines agreed that the outcomes ofpre-clinical trials of all three vaccines were assessed good thanks toVietnamese units’ close coordination with prestigious vaccine producers andresearch units over the world and their compliance with international standardsand procedures in vaccine research and development.

Speaking at the meeting, Deputy Prime Minister Vu Duc Dam,who is head of the National Steering Committee for COVID-19 Prevention andControl, hailed efforts made by the Ministries of Health and Science andTechnology, and vaccine research and development units.

He requested extra efforts to speed updomestically-developed vaccine research and production.

At the event, the Health Ministry affirmed that it has nopolicy that allows businesses and companies to import COVID-19 vaccines./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

🎶 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

♔ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

♛ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|